These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 29593249

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
    Itoh M, Kawagoe S, Tamai K, Nakagawa H, Asahina A, Okano HJ.
    J Dermatol Sci; 2020 Jun; 98(3):163-172. PubMed ID: 32376152
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of hereditary epidermolysis bullosa: updates and future prospects.
    Hsu CK, Wang SP, Lee JY, McGrath JA.
    Am J Clin Dermatol; 2014 Feb; 15(1):1-6. PubMed ID: 24402870
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY.
    JCI Insight; 2019 Oct 03; 4(19):. PubMed ID: 31578311
    [Abstract] [Full Text] [Related]

  • 9. Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing.
    Bonafont J, Mencía A, Chacón-Solano E, Srifa W, Vaidyanathan S, Romano R, Garcia M, Hervás-Salcedo R, Ugalde L, Duarte B, Porteus MH, Del Rio M, Larcher F, Murillas R.
    Mol Ther; 2021 Jun 02; 29(6):2008-2018. PubMed ID: 33609734
    [Abstract] [Full Text] [Related]

  • 10. Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
    Perdoni C, Osborn MJ, Tolar J.
    Transl Res; 2016 Feb 02; 168():50-58. PubMed ID: 26073463
    [Abstract] [Full Text] [Related]

  • 11. Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa.
    Liao Y, Itoh M, Yang A, Zhu H, Roberts S, Highet AM, Latshaw S, Mitchell K, van de Ven C, Christiano A, Cairo MS.
    Cell Transplant; 2014 Mar 02; 23(3):303-17. PubMed ID: 23394106
    [Abstract] [Full Text] [Related]

  • 12. Efficient Gene Reframing Therapy for Recessive Dystrophic Epidermolysis Bullosa with CRISPR/Cas9.
    Takashima S, Shinkuma S, Fujita Y, Nomura T, Ujiie H, Natsuga K, Iwata H, Nakamura H, Vorobyev A, Abe R, Shimizu H.
    J Invest Dermatol; 2019 Aug 02; 139(8):1711-1721.e4. PubMed ID: 30831133
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
    Gache Y, Baldeschi C, Del Rio M, Gagnoux-Palacios L, Larcher F, Lacour JP, Meneguzzi G.
    Hum Gene Ther; 2004 Oct 02; 15(10):921-33. PubMed ID: 15585108
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular therapies for inherited epidermolysis bullosa.
    Has C.
    G Ital Dermatol Venereol; 2016 Aug 02; 151(4):397-402. PubMed ID: 27149615
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.